Quanterix is a life sciences company that develops and provides ultra-sensitive diagnostic solutions for brain injuries, cancer and heart diseases.Read more
Quanterix's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 1.8B. Over the last four quarters, Quanterix's revenue has grown by 107.2%. Specifically, in Q1 2021's revenue was $27.2M; in Q4 2020, it was $26.1M; in Q3 2020, it was $31.4M; in Q2 2020, Quanterix's revenue was $13.1M.
No recent acquisitions found related to Quanterix
No recent investments found related to Quanterix